Isracann Biosciences Inc.
ISCNF · OTC
8/31/2022 | 5/31/2022 | 2/28/2022 | 11/30/2021 | |
|---|---|---|---|---|
| Market Cap | $8 | $10 | $14 | $12 |
| - Cash | $0 | $0 | $0 | $1 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $8 | $10 | $14 | $11 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | -$0 | -$0 |
| % Margin | – | – | – | – |
| EBITDA | -$0 | -$3 | -$1 | -$1 |
| % Margin | – | – | – | – |
| Net Income | -$0 | -$3 | -$1 | -$1 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.002 | -0.017 | -0.004 | -0.006 |
| % Growth | 88.4% | -309.5% | 30% | – |
| Operating Cash Flow | -$0 | -$0 | -$1 | -$1 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$1 | -$1 |